Wellington Management Group Portfolio holdings
Wellington Management Group, founded in 1928 by Walter L. Morgan and headquartered in Boston, Massachusetts, is one of the world’s largest independent asset management firms, overseeing trillions in assets for a diverse client base including pension funds, endowments, and mutual fund investors. Renowned for its active management approach, Wellington offers a broad range of investment strategies across equities, fixed income, multi-asset, and alternative investments, emphasizing deep research and long-term partnerships with clients. The firm gained early fame for launching the Wellington Fund, one of the first balanced mutual funds, and has since maintained a reputation for disciplined, collaborative portfolio management. With a global presence and a focus on customized solutions, Wellington remains a trusted name in institutional and retail investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$1.64B |
| 2 |
Microsoft
MSFT
|
+$1.44B |
| 3 |
NVIDIA
NVDA
|
+$1.17B |
| 4 |
Gilead Sciences
GILD
|
+$1.08B |
| 5 |
Eli Lilly
LLY
|
+$996M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$1.38B |
| 2 |
Apple
AAPL
|
+$1.21B |
| 3 |
United Parcel Service
UPS
|
+$1.06B |
| 4 |
T-Mobile US
TMUS
|
+$908M |
| 5 |
McDonald's
MCD
|
+$883M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.86% |
| 2 | Financials | 15.98% |
| 3 | Healthcare | 15.38% |
| 4 | Consumer Discretionary | 9.68% |
| 5 | Industrials | 9.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1626
Absci
ABSI
$1.32B
| $972K | ﹤0.01% |
378,261
+55,142
| +17% | +$155K |
|
1627
Olema Pharmaceuticals
OLMA
$1B
| $971K | ﹤0.01% |
228,021
-1,245,658
| -85% | -$5.55M |
|
1628
State Street Utilities Select Sector SPDR ETF
XLU
$22.9B
| $965K | ﹤0.01% |
23,640
-70,064
| -75% | -$2.79M |
|
1629
Chemed
CHE
$7.07B
| $958K | ﹤0.01% |
1,967
-47
| -2% | -$26.8K |
|
1630
Trevi Therapeutics
TRVI
$2.59B
| $941K | ﹤0.01% |
171,982
+44,530
| +35% | +$277K |
|
1631
Afya
AFYA
$1.31B
| $932K | ﹤0.01% |
52,203
| – | – |
|
1632
OP Bancorp
OPBK
$232M
| $913K | ﹤0.01% |
70,299
| – | – |
|
1633
Compass Therapeutics
CMPX
$344M
| $905K | ﹤0.01% |
348,040
+125,535
| +56% | +$259K |
|
1634
Fulcrum Therapeutics
FULC
$273M
| $870K | ﹤0.01% |
+126,402
| New | +$676K |
|
1635
iShares MSCI Australia ETF
EWA
$1.39B
| $866K | ﹤0.01% |
+32,902
| New | +$820K |
|
1636
United Rentals
URI
$67.2B
| $857K | ﹤0.01% |
1,138
+312
| +38% | +$209K |
|
1637
Hershey
HSY
$35.2B
| $856K | ﹤0.01% |
5,160
-6,211
| -55% | -$1.02M |
|
1638
Aflac
AFL
$64.9B
| $856K | ﹤0.01% |
8,114
-2,197
| -21% | -$231K |
|
1639
State Street Communication Services Select Sector SPDR ETF
XLC
$22.3B
| $848K | ﹤0.01% |
+7,815
| New | +$770K |
|
1640
Summit Therapeutics
SMMT
$10.4B
| $845K | ﹤0.01% |
39,694
-798
| -2% | -$18.2K |
|
1641
Ligand Pharmaceuticals
LGND
$5.76B
| $838K | ﹤0.01% |
7,370
-192
| -3% | -$20.5K |
|
1642
Trump Media & Technology Group
DJT
$2.73B
| $835K | ﹤0.01% |
46,270
+2,351
| +5% | +$51.1K |
|
1643
Aquestive Therapeutics
AQST
$464M
| $812K | ﹤0.01% |
245,299
+39,755
| +19% | +$114K |
|
1644
Hormel Foods
HRL
$13.8B
| $811K | ﹤0.01% |
26,795
+4,014
| +18% | +$121K |
|
1645
CALL
Arm
ARM
$256B
| $796K | ﹤0.01% |
+1,154
| New | +$143K |
|
1646
BioCryst Pharmaceuticals
BCRX
$2.28B
| $778K | ﹤0.01% |
86,778
-4,570
| -5% | -$42.6K |
|
1647
Dollar General
DG
$28B
| $771K | ﹤0.01% |
6,744
+3,102
| +85% | +$308K |
|
1648
Arrowhead Research
ARWR
$11.9B
| $763K | ﹤0.01% |
48,285
-4,329
| -8% | -$62.1K |
|
1649
IDEAYA Biosciences
IDYA
$3.42B
| $753K | ﹤0.01% |
35,835
-651
| -2% | -$12.5K |
|
1650
Jack Henry & Associates
JKHY
$10.9B
| $734K | ﹤0.01% |
4,074
+389
| +11% | +$69.1K |
|
Similar funds
Wellington Management Group's Q2 2025 Portfolio in Review
As of Q2 2025, Wellington Management Group held 2,080 positions worth $551B, up 6% from $520B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Wellington Management Group's Q2 2025 filing shows 139 new, 795 increased, 834 reduced and 147 closed positions. Its largest new stake was Amrize Ltd: 7,812,891 shares worth $388M. The largest sale was Procter & Gamble, an estimated $1.38B.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.
- Wellington Management Group's largest Q2 2025 buy was Amrize Ltd: 7,812,891 shares worth $388M.
- Wellington Management Group added most to Alphabet (Google) Class A in Q2 2025, an estimated $1.64B increase.
- Wellington Management Group's biggest Q2 2025 reduction was Procter & Gamble, cutting an estimated $1.38B.
- Wellington Management Group fully exited iShares Russell 1000 Growth ETF in Q2 2025, selling an estimated $464M.
- Wellington Management Group's ten largest holdings make up 25% of its $551B portfolio in Q2 2025.
- Wellington Management Group opened 139 new positions and closed 147 in Q2 2025.
- Wellington Management Group's portfolio value rose 6% quarter-over-quarter to $551B.
Based on Wellington Management Group's 13F filing for Q2 2025, filed 14 Aug 2025.